OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
Generic: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
NorthStar RxLLCManufacturer
ORALRoute
OLMESARTAN MEDOXOMILActive Substance
2023-06-01Original Approval
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA204801, sponsored by MACLEODS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
FATIGUE
17 reports
2
DIARRHOEA
15 reports
3
ASTHENIA
13 reports
4
DIZZINESS
11 reports
5
NAUSEA
9 reports
6
VOMITING
9 reports
7
DRUG INEFFECTIVE
8 reports
8
HEADACHE
8 reports
9
DECREASED APPETITE
7 reports
10
DYSPNOEA
7 reports